Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesApr 3, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 3, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 30, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 30, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 28, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 27, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 23, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 13, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2018View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-137

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information